CPH 0.00% 0.9¢ creso pharma limited

There's always a turning point, page-50

  1. 451 Posts.
    lightbulb Created with Sketch. 105

    I think it really comes down to whether you believe management has finally found their footing with Mernova and the rec direction (recent sales are promising but dependent on export license receipt???), or if you think they will throw away their cash like they have done previously; as well as whether you believe in the viability of the sector as a whole.

    To answer your question specifically, they are not further down the track because they oversold how quickly the whole Mernova package would be set up including construction, licenses, distribution and the actual growing of the product, they didn't actually start selling from Mernova until last year and they have only recently been approved the sales license for the rec market in Canada. They effed around with a bunch of different products and wasted a lot of money up until this point, however, personally I think it's worth a punt today considering their cash position doesn't look too bad right now as far as I can tell and they finally have their facility up and running which has always been their selling point, but I can understand the viewpoint of the bears as well.

    Should be noted that the US 625k Israel order was in July so won't be included in the upcoming half yearly report.


 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.